|
C9ORF30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.54839968308829E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77019998448947E-09 |
| Normal-vs-Stage2 |
3.176400E-02 |
| Normal-vs-Stage3 |
2.11329997945597E-09 |
| Normal-vs-Stage4 |
1.81055170855871E-12 |
| Stage1-vs-Stage2 |
1.040020E-01 |
| Stage1-vs-Stage3 |
3.863800E-01 |
| Stage1-vs-Stage4 |
4.230800E-04 |
| Stage2-vs-Stage3 |
4.757800E-02 |
| Stage2-vs-Stage4 |
8.784700E-04 |
| Stage3-vs-Stage4 |
1.611850E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.92799995360582E-09 |
| Normal-vs-AfricanAmerican |
4.04170000000148E-05 |
| Normal-vs-Asian |
4.31749999996178E-06 |
| Caucasian-vs-AfricanAmerican |
8.267400E-01 |
| Caucasian-vs-Asian |
3.729800E-01 |
| AfricanAmerican-vs-Asian |
6.676200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.0753000002679E-07 |
| Normal-vs-Female |
3.42189609980892E-11 |
| Male-vs-Female |
3.751200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.02820000081172E-08 |
| Normal-vs-Age(41-60Yrs) |
1.82049999519762E-08 |
| Normal-vs-Age(61-80Yrs) |
1.23750000247114E-08 |
| Normal-vs-Age(81-100Yrs) |
3.377400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.064200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.937200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.954000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.863600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.028600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.756000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.816300E-03 |
| Classical-VS-Follicular |
6.451400E-01 |
| Classical-VS-Other |
8.835600E-01 |
| Classical-VS-Normal |
4.80200001984343E-09 |
| Tall-VS-Follicular |
1.218220E-02 |
| Tall-VS-Other |
4.191400E-01 |
| Tall-VS-Normal |
1.58000001970748E-09 |
| Follicular-VS-Other |
9.618400E-01 |
| Follicular-VS-Normal |
3.67940000000067E-05 |
| Other-VS-Normal |
2.027600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.01109999986571E-07 |
| Normal-vs-N1 |
2.30339969320426E-10 |
| N0-vs-N1 |
2.446400E-02 |
|
|
